Table 2.
Number of participants with abnormalities in the routine blood test and in the most used inflammatory markers, categorized by patients with COVID-19, bacterial pneumonia, or influenza.
| COVID-19 |
Bacterial pneumonia |
Influenza |
|||
|---|---|---|---|---|---|
| N/n (%) | N/n (%) | P valuea | N/n (%) | P valuea | |
| Leukocytosis (>9.5 × 109/L) |
3/48 (6.25%) |
12/46 (26.09%) |
0.011 | 3/48 (6.25%) |
1.000 |
| Leukopenia (<3.5 × 109/L) |
11/48 (22.92%) |
1/46 (2.17%) |
0.004 | 3/48 (6.25%) |
0.040 |
| Neutrophilia (>6.3 × 109/L) |
5/48 (10.42%) |
14/46 (30.43%) |
0.021 | 8/48 (16.67%) |
0.371 |
| Neutrophilia (%) (>75%) |
5/48 (10.42%) |
10/46 (21.74%) |
0.165 | 17/48 (35.42%) |
0.004 |
| Lymphopenia (<0.8 × 109/L) |
14/48 (29.17%) |
3/46 (6.52%) |
0.006 | 22/48 (45.83%) |
0.140 |
| Lymphopenia (%) (<20%) | 13/48 (27.08%) |
15/46 (32.61%) |
0.558 | 38/48 (79.17%) |
<0.001 |
| Monocytosis (>0.6 × 109/L) |
7/48 (14.58%) |
16/46 (34.78%) |
0.023 | 33/48 (68.75%) |
<0.001 |
| Monocytosis (%) (>10%) | 16/48 (33.33%) |
7/46 (15.23%) |
0.041 | 33/48 (68.75%) |
0.001 |
| Eosinopenia (<0.02 × 109/L) |
36/48 (75.00%) |
8/46 (17.39%) |
<0.001 | 29/48 (60.42%) |
0.127 |
| Eosinopenia (%) (<0.4%) |
36/48 (75.00%) |
9/46 (19.57%) |
<0.001 | 30/48 (62.50%) |
0.186 |
| NLR (>3.72) | 12/48 (25.00%) |
14/46 (30.43%) |
0.556 | 35/48 (72.92%) |
<0.001 |
| LMR (<2.74) | 20/48 (41.67%) |
16/46 (34.78%) |
0.530 | 48/48 (100%) |
<0.001 |
| CRP (>10 mg/L) |
26/48 (54.17%) | 27/42 (64.29%) |
0.330 | 12/15 (80.00%) | 0.129 |
| SAA (>10 mg/L) |
40/48 (83.33%) | 24/42 (57.14%) | 0.010 | 14/15 (93.33%) | 0.673 |
a
Compared with COVID-19.